chicago med spa semaglutide Medical in Lincoln Square, IL Considering GLP-1s? Already taking one?

Understanding your genetic predispositions in GLP-1 and glucose-sensing pathways can help you and your provider make data-informed decisions about compounded GLP-1 therapies (semaglutide, tirzepatide) versus lifestyle interventions, or whether a combination approach is most suitable for your metabolic health goals

For at least 20 years, pharma companies led by Novo Nordisk and Eli Lilly have been trying to find a better alternative

After observing the weight loss benefits in diabetes patients, other GLP-1s were developed and approved specifically to treat obesity

The genuine record is data: measured percentage changes in weight, liver fat, and blood sugar from randomized trials (Jastreboff et al., 2023

Combination Potential Here's where things get interesting